Table of Contents EMERGING INFECTIOUS DISEASES Volume 2, Number 3 July-September 1996 Table of Contents, Instructions to Authors, and General Information Perspectives * Molecular Approaches to the Identification of Unculturable Infectious Agents, S-J. Gao and P.S. Moore * DNA Vaccines for Emerging Infectious Diseases: What If? R.G. Whalen Synopses * Conjugate Vaccines and the Carriage of Haemophilus influenzae Type b, M.L. Barbour * Application of Molecular Techniques to the Diagnosis of Microsporidial Infection, D.P. Fedorko and Y.M. Hijazi * Coccidioidomycosis: A Reemerging Infectious Disease, T.N. Kirkland and J. Fierer * Antibody-Based Therapies for Emerging Infectious Diseases, A. Casadevall Dispatches * HIV-1 Group O Virus Identified for the First Time in the United States, M.A. Rayfield, P. Sullivan, C. I. Bandea, R. A. Otten, C.P. Pau, D. Pieniazek, S. Subbarao, P. Simon, C. A. Schable, A. Wright, J. Ward, and G. Schochetman * Two Morbilliviruses Implicated in Bottlenose Dolphin Epizootics, J.K. Taubenberger, M. Tsai, A.E. Krafft, J.H. Lichy, A.H. Reid, F.Y. Schulman, and T.P. Lipscomb * An Outbreak of Spotted Fever Rickettsiosis in U.S. Army Troops Deployed to Botswana, B.L. Smoak, J.B. McClain, J.F. Brundage, L. Broadhurst, D.J. Kelly, G.A. Dasch, and R.N. Miller * A Highly Heterogeneous HIV-1 Epidemic in the Central African Republic, M. Massanga, J. Ndoyo, D.J. Hu, C-P. Pau, S. Lee-Thomas, R. Hawkins, D. Senekian, M.A. Rayfield, J.R. George, A. Zengais, N.N. Yatere, V. Yossangang, A Samori, G. Schochetman, and T. J. Dondero * Legionella-Like Amebal Pathogens—Phylogenetic Status and Possible Role in Respiratory Disease, A. Adeleke, J. Pruckler, R. Benson, T. Rowbotham, M. Halablab, and B. Fields * Role of Enterovirus 71 in Acute Flaccid Paralysis After the Eradication of Poliovirus in Brazil, E.E. da Silva, M.T. Winkler, F. Ferreira, and M. Pallansch * Bancroftian Filariasis Distribution and Diurnal Temperature Differences in the Southern Nile Delta, D.F. Thompson, J.B. Malone, M. Harb, R. Faris, O.K. Huh, A.A. Buck, and B.L. Cline Sentinel * Surveillance for Yellow Fever in Kenya, 1993 to 1995, E.J. Sanders, P. Borus, G. Ademba, G. Kuria, P.M. Tukei, and J.W. LeDuc * Serologic Evidence for the Presence in Pteropus Bats of a Paramyxovirus Related to Equine Morbillivirus, P.L. Young, K. Halpin, P.W. Selleck, H. Field, J.L. Gravel, M.A. Kelly, and J.S. Mackenzie Letters * Acute Cervical Lymphadenopathy, M.B. Pasticci, F. Baldelli, F. Bistoni, C. Piersimoni, G. Sbaraglia, G. Stagni, and S. Pauluzzi * AIDS: Déjà Vu in Ancient Egypt? R.J. Ablin News and Notes * International Meeting on Research Advances and Rabies Control in the Americas, C.E. Rupprecht * Symposium Notice, Infect. Dis. Assoc. of California For further information about receiving EID electronically or technical help, send an e-mail to eidhelp@cidod1.em.cdc.gov. This material is provided by the National Center for Infectious Diseases--a sub-unit of CDC/ATSDR. It has been cleared for public distribution and is authentic if accessed directly from lists@list.cdc.gov or eid-toc@list.cdc.gov. ---------------------------------------------------------------------------- Editors Editor Joseph E. McDade, Ph.D., National Center for Infectious Diseases Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA Perspectives Editor Stephen S. Morse, Ph.D.,The Rockefeller University, New York, New York, USA Synopses Editor Phillip J. Baker, Ph.D., Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA Dispatches Editor Stephen Ostroff, M.D., National Center for Infectious Diseases, CDC, Atlanta, Georgia, USA Managing Editor Polyxeni Potter, M.A., National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA Liaison Representatives Anthony I. Adams, M.D., Chief Medical Adviser, Commonwealth Department of Human Services and Health, Canberra, Australia David Brandling-Bennett, M.D., Director, Division of Communicable Diseases, Pan American Health Organization, World Health Organization Washington, D.C., USA Gail Cassell, Ph.D., Liaison to American Society for Microbiology University of Alabama at Birmingham Birmingham, Alabama, USA Richard A. Goodman, M.D., M.P.H., Editor, MMWR, CDC, Atlanta, Georgia, USA William Hueston, D.V.M., Ph.D, Acting Leader, Center for Animal Health Monitoring, Centers for Epidemiology and Animal Health Veterinary Services, Animal and Plant Health Inspection Service, U.S. Dept. of Agriculture Fort Collins, Colorado, USA James LeDuc, Ph.D., Advisor for Arboviral Diseases, Division of Communicable Diseases, World Health Organization, Geneva, Switzerland Joseph Losos, M.D., Director General, Laboratory Center for Disease Control Ontario, Canada Gerald L. Mandell, M.D., Liaison to Infectious Diseases Society of America, University of Virginia Medical Center, Charlottesville, Virginia, USA Phillip P. Mortimer, M.D., Director, Virus Reference Division Central Public Health Laboratory London, United Kingdom Robert Shope, M.D., Director, Yale Arbovirus Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA Natalya B. Sipachova, M.D., Ph.D. Scientific Editor Russian Republic Information & Analytic Centre Moscow, Russia Bonnie Smoak, M.D. U.S. Army Medical Research Unit--Kenya Unit 64109 Box 401 APO AE 09831-4109 Robert Swanepoel, B.V.Sc., Ph.D., Head, Special Pathogens Unit, National Institute for Virology, Sandrinham 2131, South Africa Roberto Tapia, M.D. Director General de Epidemiología Dirección General de Epidemiología Secretaría de Salud México Editorial and Computer Support Emerging Infectious Diseases receives editorial and computer support from the Office of Planning and Health Communication, National Center for Infectious Diseases. Editorial Support Maria T. Brito Beatrice T. Divine, M.B.A. Carol D. Snarey, M.A. Production Rita M. Furman, M.S. Electronic Distribution Carol Y. Crawford David L. Smith Cheryl G. Shapiro, M.S. Emerging Infectious Diseases Emerging Infectious Diseases is published four times a year by the National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, Mailstop C-12, Atlanta, GA 30333, USA. Telephone 404-639-3967, fax 404-639-3039, e-mail eideditor@cidod1.em.cdc.gov. The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of CDC or the institutions with which the authors are affiliated. All materials published in Emerging Infectious Diseases are in the public domain and may be used and reprinted without special permission; proper citation, however, is appreciated. Use of trade names is for identification only and does not imply endorsement by the Public Health Service or by the U.S. Department of Health and Human Services. Instructions to Authors Editorial Policy and Call for Articles The goals of Emerging Infectious Diseases (EID) are to promote the recognition of new and reemerging infectious diseases and to improve the understanding of factors involved in disease emergence, prevention, and elimination. Emerging infectious are new or newly identified pathogens or syndromes that have been recognized in the past two decades. Reemerging infections are known pathogens or syndromes that are increasing in incidence, expanding into new geographic areas, affecting new populations, or threatening to increase in the near future. EID has an international scope and is intended for professionals in infectious diseases and related sciences. We welcome contributions from infectious disease specialists in academia, industry, clinical practice, and public health as well as from specialists in economics, demography, sociology, and other disciplines whose study elucidates the factors influencing the emergence of infectious diseases. Inquiries about the suitability of proposed articles may be directed to the editor at 404-639-3967 (telephone), 404-727-8737 (fax), or eideditor@cidod1.em.cdc.gov (e-mail). EID will be published in English and will feature three types of articles: Perspectives, Synopses, and Dispatches. The purpose and requirements of each type of article are described in detail below. Instructions to Authors Manuscripts should be prepared according to the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals" (JAMA 1993:269[17]: 2282-6). Begin each of the following sections on a new page and in this order: title page, abstract, text, acknowledgments, references, each table, figure legends, and figures. On the title page, give complete information about each author (full names and highest degree). Give current mailing address for correspondence (include fax number and e-mail address). Follow Uniform Requirements style for references. Consult List of Journals Indexed in Index Medicus for accepted journal abbreviations. Tables and figures should be numbered separately (each beginning with 1) in the order of mention in the text. Double-space everything, including the title page, abstract, references, tables, and figure legends. Italicize scientific names of organisms from species name all the way up, except for vernacular names (viruses that have not really been speciated, such as coxsackievirus and hepatitis B; bacterial organisms, such as pseudomonads, salmonellae, and brucellae). All articles will be reviewed by independent reviewers. The Editor reserves the right to edit articles for clarity and to modify the format to fit the publication style of Emerging Infectious Diseases. Documents sent in hardcopy should also be sent on diskette, or by e-mail. Acceptable electronic formats for text are ASCII, WordPerfect, AmiPro, DisplayWrite, MS Word, MultiMate, Office Writer, WordStar, or Xywrite. Send graphics documents in Corel Draw, Harvard Graphics, Freelance, .TIF (TIFF), .GIF (CompuServe), .WMF (Windows Metafile), .EPS (Encapsulated Postscript), or .CGM (Computer Graphics Metafile). The preferred font for graphics files is Helvetica. If possible, convert Macintosh files into one of the suggested formats. Submit photographs in glossy, camera-ready photographic prints. Send all manuscripts and correspondence to the Editor, Emerging Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop C-12, Atlanta, GA 30333, USA, or by e-mail on the Internet to eideditor@cidod1.em.cdc.gov. Perspectives: Contributions to the Perspectives section should provide insightful analysis and commentary about new and reemerging infectious diseases or related issues. Perspectives may also address factors known to influence the emergence of infectious diseases, including microbial adaption and change; human demographics and behavior; technology and industry; economic development and land use; international travel and commerce; and the breakdown of public health measures. Articles should be approximately 3,500 words and should include references, not to exceed 40. Use of additional subheadings in the main body of the text is recommended. If detailed methods are included, a separate section on experimental procedures should immediately follow the body of the text. Photographs and illustrations are optional. Provide a short abstract (150 words) and a brief biographical sketch. Synopses: Submit concise reviews of infectious diseases or closely related topics. Preference will be given to reviews of new and emerging diseases; however, timely updates of other diseases or topics are also welcome. Synopses should be approximately 3,500 words and should include references, not to exceed 40. Use of additional subheadings in the main body of the text is recommended. If detailed methods are included, a separate section on experimental procedures should immediately follow the body of the text. Photographs and illustrations are encouraged. Provide a short abstract (150 words) and a brief biographical sketch. Dispatches: Provide brief updates on trends in infectious diseases or infectious disease research. Dispatches (1,000 to 1,500 words of text) should be in a letter to the editor format and should not be divided into sections. Dispatches should begin with a brief introductory statement about the relationship of the topic to the emergence of infectious diseases. Provide references, not to exceed 10, and figures or illustrations, not to exceed two. =========================================================================